Tau, Diabetes and Insulin.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
entrez: 26 2 2020
pubmed: 26 2 2020
medline: 9 4 2020
Statut: ppublish

Résumé

Tau protein which was discovered in 1975 [310] became of great interest when it was identified as the main component of neurofibrillary tangles (NFT), a pathological feature in the brain of patients with Alzheimer's disease (AD) [39, 110, 232]. Tau protein is expressed mainly in the brain as six isoforms generated by alternative splicing [46, 97]. Tau is a microtubule associated proteins (MAPs) and plays a role in microtubules assembly and stability, as well as diverse cellular processes such as cell morphogenesis, cell division, and intracellular trafficking [49]. Additionally, Tau is involved in much larger neuronal functions particularly at the level of synapses and nuclei [11, 133, 280]. Tau is also physiologically released by neurons [233] even if the natural function of extracellular Tau remains to be uncovered (see other chapters of the present book).

Identifiants

pubmed: 32096044
doi: 10.1007/978-981-32-9358-8_21
doi:

Substances chimiques

Insulin 0
tau Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-287

Auteurs

Maud Gratuze (M)

Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.

Aurélie Joly-Amado (A)

Department of Molecular Pharmacology and Physiology, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.

Luc Buee (L)

University of Lille, INSERM, CHU-Lille, UMR-S 1172 - JPArc, "Alzheimer & Tauopathies", Lille, France.

Didier Vieau (D)

University of Lille, INSERM, CHU-Lille, UMR-S 1172 - JPArc, "Alzheimer & Tauopathies", Lille, France.

David Blum (D)

University of Lille, INSERM, CHU-Lille, UMR-S 1172 - JPArc, "Alzheimer & Tauopathies", Lille, France. david.blum@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH